Collectively, these studies show that the CD134–CD252 pathway is involved in regulating inflammation by reducing the production of cytokines such as IL-4 and IL-10, known to perpetuate inflammation in SLE. This evidence concerns the gene TNFRSF4 and systemic lupus erythematosus.